BB BIOTECH AG
Follow13F filer, CIK 924223, SCHAFFHAUSEN, Switzerland
BB BIOTECH AG filed a 13F-NT notice for the quarter ended 2026-03-31 on 2026-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-NT 0001104659-26-061379
This filer reports no holdings of its own for Q1 2026. It filed a 13F-NT notice, and its holdings are in the report of . How notices are handled.
Changes against Q4 2025 are not shown: it was a notice, with the holdings in another manager's report (0 positions on file), so every position would read as new.
Part of the filer group Bellevue Group AG
Bellevue Asset Management AGBellevue Asset Management (UK) Ltd.
- Bellevue Asset Management AG
- Bellevue Asset Management (UK) Ltd.
- Bellevue Group AG
- Bellevue Asset Management AG
Stakes and trades reported after 2026-03-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- YARW YARROW BIOSCIENCE INC: 13G 1,000,000 shares, 10.6% of the class, 13G filed 2026-10-07, 0001104659-26-114282Timeline
Accepted , ingested
How Q1 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-NT 0001104659-26-061379 | notice | 2026-05-15 | acceptance time not in the bulk data set |